ProjectVALIdation of a Treatment Decision Pathway for Andexanet Alfa- VALIDA -

Basic data

Title:
VALIdation of a Treatment Decision Pathway for Andexanet Alfa- VALIDA -
Duration:
01/10/2024 to 31/10/2026
Abstract / short description:
VALIdation of a Treatment Decision Pathway for Andexanet Alfa
- VALIDA -

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurovascular Diseases
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Dresden, Sachsen, Germany
Help

will be deleted permanently. This cannot be undone.